Peptomyc announces a new equity financing round of 11.4M€ led by AurorA Science and supported by Alta Life Sciences, HealthEquity, CDTI and business angels

by Alta Life Sciences

Peptomyc is relying on a strong syndicate of life sciences investors. This investment was led by AurorA Science and substantially supported by existing investors including Alta Life Sciences, HealthEq...

Read more

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

by Ysios Capital

Minoryx is backed by a syndicate of experienced investors, which includes Caixa Capital Risc, Roche Venture Fund, Ysios Capital, Kurma Partners, Fund+, Chiesi Ventures, S.R.I.W, Idinvest, SFPI-FPIM, H...

Read more

Versantis raises CHF 4,4 million in series a financing to advance new generation of liver disease medicines

by Healthequity

Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closi...

Read more

Minoryx Therapeutics raises €21.3M in Series B funding round

by Ysios Capital

The funding round was led by Fund+, joined by SFPI-FPIM, S.R.I.W. and Sambrinvest, in addition to all Series A investors (Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi V...

Read more

Peptomyc obtiene 4,2 millones de euros en una ronda de financiación liderada por Alta Life Sciences

by AltamarCAM Partners

La inversión ha sido liderada por Alta Life Sciences Spain I FCR e incluye a los actuales inversores Healthequity así como a “business angels” que participaron en la primera ronda de inversión ...

Read more

El Colegio de Médicos invierte en la biotecnológica Minoryx Therapeutics

by La Vanguardia

Healthequity, impulsada por el Colegio de Médicos de Barcelona y gestionada por Grupo MED Corporativo y el grupo financiero Riva y García, ha invertido 750.000 euros en la empresa biotecnológica Mi...

Read more

El ICF inyecta 9,3 millones en fondos de capital riesgo

by Expansión

Caixa Capital Risc, Suma Capital y Healthequity recibieron el año pasado nuevos recursos de la agencia crediticia de la Generalitat

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Addleshaw Goddard advises Unigrains Iber...

by Addleshaw Goddard

This is the first investment made by the Unigrains Iberia subsidiary i...

Photos Stream